Aurita Bioscience

Aurita is a 3D bioscience company focused on developing advanced in vitro models that better replicate the complexity of living systems. The company's core technology is called iVITA (in Vitro Immuno Therapy Assays), which comprises various proprietary technologies and protocols to create more physiologically relevant 3D cell culture environments. A key component is Aurita's LLS microgels, which can be bioconjugated with extracellular matrix proteins like collagen and fibronectin to support cell adhesion, migration and signaling in 3D. The LLS particles create a network of channels and crevices that mimic capillary structures, allowing cells to migrate, receive mechanical cues, and follow cytokine gradients. This enables more complex and realistic growth of cells compared to traditional 2D cultures. Aurita's technology aims to overcome limitations of conventional cell culture approaches that rely on simplified monolayers grown on plastic surfaces, which lack clinical relevance. By recreating key aspects of the in vivo cellular microenvironment, Aurita's platform is designed to provide more predictive models for applications like drug discovery and toxicity testing.